Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Buszewicz M

doi:10.1016/s0140-6736(18)32213-x

← Today's brief

Study

Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Gazzard G et al. · Lancet (London, England) · Saturday, March 9, 2019

Funding Not reported

Source

Gazzard G et al.. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet (London, England). Saturday, March 9, 2019.
doi:10.1016/s0140-6736(18)32213-xRead original ↗

Generated, then checked claim-by-claim against the source · how this brief was built →

Physician-designed methodology · Amr Saad, MD MBA

Automated evidence summary, checked against the source. Not medical advice. Verify with the original publication.